Aspirin for Primary Prevention of Cardiovascular Events in People with Diabetes: a Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American...

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2010 May 29

PMID 20508233

Citations 71

Authors

Michael Pignone

Mark J Alberts

John A Colwell

Mary Cushman

Silvio E Inzucchi

Debabrata Mukherjee

Robert S Rosenson

Craig D Williams

Peter W Wilson

M Sue Kirkman

Affiliations

Soon will be listed here.

Citing Articles

Diabetes mellitus associated neurovascular lesions in the retina and brain: A review.

Sinclair S, Miller E, Talekar K, Schwartz S Front Ophthalmol (Lausanne). 2024; 2:1012804.

PMID: 38983558 PMC: 11182219. DOI: 10.3389/fopht.2022.1012804.

The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis.

Sohn M, Lim S Int J Mol Sci. 2024; 25(5).

PMID: 38473840 PMC: 10932209. DOI: 10.3390/ijms25052593.

Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights.

Jia G, Bai H, Mather B, Hill M, Jia G, Sowers J Int J Mol Sci. 2024; 25(2).

PMID: 38255878 PMC: 10815704. DOI: 10.3390/ijms25020804.

Cardiovascular Protection of Aspirin in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis.

Chen T, Deng Y, Gong R Curr Vasc Pharmacol. 2023; 22(4):287-296.

PMID: 37259222 DOI: 10.2174/1570161121666230530154647.

Aspirin Use among Saudi Adults: The Prevalence and Users' Characteristics.

Alghadeer S, Alwhaibi A, Alhossan A, Babelghaith S, Mubarak A, Samreen S Saudi Pharm J. 2022; 30(4):340-346.

PMID: 35527833 PMC: 9068572. DOI: 10.1016/j.jsps.2022.02.003.

References

de Gaetano G . Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet. 2001; 357(9250):89-95. DOI: 10.1016/s0140-6736(00)03539-x. View

De Berardis G, Sacco M, Evangelista V, Filippi A, Giorda C, Tognoni G . Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus.... Trials. 2007; 8:21. PMC: 2014771. DOI: 10.1186/1745-6215-8-21. View

Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N . Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA. 2008; 300(18):2134-41. DOI: 10.1001/jama.2008.623. View

Ridker P, Cook N, Lee I, Gordon D, Gaziano J, Manson J . A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005; 352(13):1293-304. DOI: 10.1056/NEJMoa050613. View

. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989; 321(3):129-35. DOI: 10.1056/NEJM198907203210301. View

Colwell J, Halushka P, Sarji K, Levine J, Sagel J, Nair R . Altered platelet function in diabetes mellitus. Diabetes. 1976; 25(2 SUPPL):826-31. View

. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators. JAMA. 1992; 268(10):1292-300. DOI: 10.1001/jama.1992.03490100090033. View

Lai K, Lam S, Chu K, Wong B, Hui W, Hu W . Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med. 2002; 346(26):2033-8. DOI: 10.1056/NEJMoa012877. View

Kearney P, Blackwell L, Collins R, Keech A, Simes J, Peto R . Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008; 371(9607):117-25. DOI: 10.1016/S0140-6736(08)60104-X. View

10.

Berger J, Roncaglioni M, Avanzini F, Pangrazzi I, Tognoni G, Brown D . Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 2006; 295(3):306-13. DOI: 10.1001/jama.295.3.306. View

11.

Buse J, Ginsberg H, Bakris G, Clark N, Costa F, Eckel R . Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2006; 30(1):162-72. DOI: 10.2337/dc07-9917. View

12.

He J, Whelton P, Vu B, Klag M . Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA. 1998; 280(22):1930-5. DOI: 10.1001/jama.280.22.1930. View

13.

Hansson L, Zanchetti A, Carruthers S, Dahlof B, Elmfeldt D, Julius S . Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998; 351(9118):1755-62. DOI: 10.1016/s0140-6736(98)04311-6. View

14.

Pignone M, Earnshaw S, Tice J, Pletcher M . Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis. Ann Intern Med. 2006; 144(5):326-36. DOI: 10.7326/0003-4819-144-5-200603070-00007. View

15.

Zhang C, Sun A, Zhang P, Wu C, Zhang S, Fu M . Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis. Diabetes Res Clin Pract. 2009; 87(2):211-8. DOI: 10.1016/j.diabres.2009.09.029. View

16.

Lev E . Aspirin resistance transient laboratory finding or important clinical entity?. J Am Coll Cardiol. 2009; 53(8):678-80. DOI: 10.1016/j.jacc.2008.11.018. View

17.

Eikelboom J, Hirsh J, Weitz J, Johnston M, Yi Q, Yusuf S . Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation. 2002; 105(14):1650-5. DOI: 10.1161/01.cir.0000013777.21160.07. View

18.

Reusch J . Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose?. J Clin Invest. 2003; 112(7):986-8. PMC: 198532. DOI: 10.1172/JCI19902. View

19.

. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice.... Lancet. 1998; 351(9098):233-41. View

20.

Patrono C . Aspirin as an antiplatelet drug. N Engl J Med. 1994; 330(18):1287-94. DOI: 10.1056/NEJM199405053301808. View